article thumbnail

STAT+: ‘Skinny labels’ on generic medicines saved Medicare $15 billion over a recent six-year period

STAT

A controversial provision of a federal law designed to speed copycat drugs to market and foster competition saved Medicare Part D nearly $15 billion from 2015 to 2021 on just 15 medicines during that period, according to a new analysis.

article thumbnail

Amazon extends $5 generic subscription service to Medicare

pharmaphorum

Amazon Pharmacy is expanding its subscription service for generic medicines, making it available to Medicare patients

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FTC targets middlemen in generic drug shortages probe

pharmaphorum

The FTC is investigating wholesalers and other middlemen in the pharma supply chain to assess their possible role in worsening shortages of generic medicines

article thumbnail

STAT+: Under pressure to thwart pharma patent abuse, the PTO proposes a new rule. But will it fly?

STAT

Patent and Trademark Office has proposed a new rule designed to stem the use of so-called patent thickets , which are wielded by pharmaceutical companies to delay the arrival of lower-cost generic medicines in the marketplace.

article thumbnail

Opinion: I went on a mind-boggling journey to get my son’s ADHD medication covered by insurance — twice

STAT

As a former editor for diabetes publications, I knew that insurance companies regularly switched people from one brand of insulin to another, or from a name brand of insulin to a generic. However, I had used generic medicine for my blood pressure without a problem, so I hoped for the best with this switch.

Insurance 104
article thumbnail

NHS drug shortages are partly a political failure | Letters

The Guardian - Pharmaceutical Industry

Roared on by the pharmaceutical industry, ministers have been using trade talks with India to push for agreement on new, extremely restrictive patent rules that would severely undermine its generic medicines industry.

article thumbnail

India's Torrent scouts for funding to make a play for larger rival Cipla: Reuters

Fierce Pharma

Two large Indian suppliers of generic medicines in the U.S. and beyond are at the center of the industry's M&A rumor mill this week. Torrent is looking for financial help to potentially make a bid for its larger rival Cipla, according to Reuters.